3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
47
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Lymphoid
1
Head & Neck
1
Endocrine
1
Conditions
Neuroendocrine Tumors
50
Pancreatic Neoplasms
6
Gastrointestinal Neoplasms
6
Stomach Neoplasms
5
Carcinoma, Hepatocellular
5
Colorectal Neoplasms
4
Rectal Neuroendocrine Tumor
3
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Liver Neoplasms
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Thyroid Neoplasms
2
Rectal Neuroendocrine Tumors
2
Rectal Neoplasms
2
Neoplasms
2
Gastrointestinal Stromal Tumors
2
Gastro-enteropancreatic neuroendocrine tumor
2
Colonic Neoplasms
2
Carcinoma, Neuroendocrine
2
Carcinoma
2
Carcinoid Tumor
2
Biliary Tract Neoplasms
2
Appendiceal Neoplasms
2
Anus Neoplasms
2
Visceral Pain
1
Serotonin Syndrome
1
Recurrence
1
Pheochromocytoma
1
Patients With Gastroenteropancreatic Neuroendocrine Tumors
1
Interventions
Poly(ADP-ribose) Polymerase Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Esophageal Squamous Cell Carcinoma
×
NET
×
Clear all
NCT04584008
2024-10-15
VISIONARY
Peking University
Phase NA
Active not recruiting
600 enrolled